Yamada S - Search Results

1

Results of a Phase II Study on the Use of Neoadjuvant Chemotherapy (FOLFIRINOX or GEM/nab-PTX) for Borderline-resectable Pancreatic Cancer (NUPAT-01).

Yamaguchi J, Yokoyama Y, Fujii T, Yamada S, Takami H, Kawashima H, Ohno E, Ishikawa T, Maeda O, Ogawa H, Kodera Y, Nagino M, Ebata T. Yamaguchi J, et al. Among authors: yamada s. Ann Surg. 2022 Jun 1;275(6):1043-1049. doi: 10.1097/SLA.0000000000005430. Epub 2022 Mar 3. Ann Surg. 2022. PMID: 35258510 Clinical Trial.

2

Correlation between copy number of mitochondrial DNA and clinico-pathologic parameters of hepatocellular carcinoma.

Yamada S, Nomoto S, Fujii T, Kaneko T, Takeda S, Inoue S, Kanazumi N, Nakao A. Yamada S, et al. Eur J Surg Oncol. 2006 Apr;32(3):303-7. doi: 10.1016/j.ejso.2006.01.002. Epub 2006 Feb 14. Eur J Surg Oncol. 2006. PMID: 16478656

3

A proposal of an appropriate surgical approach for cancer of the ampulla of Vater: retrospective analysis of 73 resected cases.

Yamada S, Fujii T, Sugimoto H, Takeda S, Inoue S, Nomoto S, Kanazumi N, Nakao A. Yamada S, et al. Hepatogastroenterology. 2007 Jan-Feb;54(73):10-4. Hepatogastroenterology. 2007. PMID: 17419221

4

Clinical implications of peritoneal cytology in potentially resectable pancreatic cancer: positive peritoneal cytology may not confer an adverse prognosis.

Yamada S, Takeda S, Fujii T, Nomoto S, Kanazumi N, Sugimoto H, Kasuya H, Kodera Y, Nagasaka T, Morita S, Nakao A. Yamada S, et al. Ann Surg. 2007 Aug;246(2):254-8. doi: 10.1097/01.sla.0000261596.43439.92. Ann Surg. 2007. PMID: 17667504 Free PMC article.

5

Frequent promoter methylation of M-cadherin in hepatocellular carcinoma is associated with poor prognosis.

Yamada S, Nomoto S, Fujii T, Takeda S, Kanazumi N, Sugimoto H, Nakao A. Yamada S, et al. Anticancer Res. 2007 Jul-Aug;27(4B):2269-74. Anticancer Res. 2007. PMID: 17695513 Free article.

6

Pancreatic cancer with paraaortic lymph node metastasis: a contraindication for radical surgery?

Yamada S, Nakao A, Fujii T, Sugimoto H, Kanazumi N, Nomoto S, Kodera Y, Takeda S. Yamada S, et al. Pancreas. 2009 Jan;38(1):e13-7. doi: 10.1097/MPA.0b013e3181889e2d. Pancreas. 2009. PMID: 18797422

7

Nonfunctioning neuroendocrine pancreatic tumors: our experience and management.

Nomura N, Fujii T, Kanazumi N, Takeda S, Nomoto S, Kasuya H, Sugimoto H, Yamada S, Nakao A. Nomura N, et al. Among authors: yamada s. J Hepatobiliary Pancreat Surg. 2009;16(5):639-47. doi: 10.1007/s00534-009-0099-1. Epub 2009 Apr 14. J Hepatobiliary Pancreat Surg. 2009. PMID: 19365596

8

Pancreatic cancer with distant metastases: a contraindication for radical surgery?

Yamada S, Fujii T, Sugimoto H, Kanazumi N, Kasuya H, Nomoto S, Takeda S, Kodera Y, Nakao A. Yamada S, et al. Hepatogastroenterology. 2009 May-Jun;56(91-92):881-5. Hepatogastroenterology. 2009. PMID: 19621722

9

Prognostic factors for survival after extended pancreatectomy for pancreatic head cancer: influence of resection margin status on survival.

Kato K, Yamada S, Sugimoto H, Kanazumi N, Nomoto S, Takeda S, Kodera Y, Morita S, Nakao A. Kato K, et al. Among authors: yamada s. Pancreas. 2009 Aug;38(6):605-12. doi: 10.1097/MPA.0b013e3181a4891d. Pancreas. 2009. PMID: 19629002

10

Middle pancreatectomy: safety and long-term results.

Shikano T, Nakao A, Kodera Y, Yamada S, Fujii T, Sugimoto H, Kanazumi N, Nomoto S, Takeda S. Shikano T, et al. Among authors: yamada s. Surgery. 2010 Jan;147(1):21-9. doi: 10.1016/j.surg.2009.04.036. Epub 2009 Aug 14. Surgery. 2010. PMID: 19682717

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,295 results

Search Page